Follow-up of MM patients who progress to PCL revealed an upward trend in SRRM2 expression on plasma cells, further demonstrating the relationship between SRRM2 expression and disease progression as well as plasma cell invasive properties in MM. This evidence concerns the gene SRRM2 and Miyoshi myopathy.